Johnson & Johnson's Options Frenzy: What You Need to Know

High-rolling investors have positioned themselves bearish on Johnson & Johnson JNJ, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in JNJ often signals that someone has privileged information.

Today, Benzinga's options scanner spotted 13 options trades for Johnson & Johnson. This is not a typical pattern.

The sentiment among these major traders is split, with 30% bullish and 61% bearish. Among all the options we identified, there was one put, amounting to $77,589, and 12 calls, totaling $614,980.

Predicted Price Range

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $142.0 and $165.0 for Johnson & Johnson, spanning the last three months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Johnson & Johnson's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Johnson & Johnson's whale activity within a strike price range from $142.0 to $165.0 in the last 30 days.

Johnson & Johnson Call and Put Volume: 30-Day Overview

Biggest Options Spotted:

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Following our analysis of the options activities associated with Johnson & Johnson, we pivot to a closer look at the company's own performance.

Where Is Johnson & Johnson Standing Right Now?

• With a volume of 4,039,338, the price of JNJ is up 0.05% at $151.22.
• RSI indicators hint that the underlying stock may be approaching overbought.
• Next earnings are expected to be released in 75 days.

What The Experts Say On Johnson & Johnson

In the last month, 5 experts released ratings on this stock with an average target price of $162.2.

Turn $1000 into $1270 in just 20 days?

20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Johnson & Johnson, targeting a price of $152. * Maintaining their stance, an analyst from Stifel continues to hold a Hold rating for Johnson & Johnson, targeting a price of $155. * Maintaining their stance, an analyst from B of A Securities continues to hold a Neutral rating for Johnson & Johnson, targeting a price of $160. * In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $181. * Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Johnson & Johnson with a target price of $163.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Johnson & Johnson with Benzinga Pro for real-time alerts.